OMGA(Delisted)
Omega TherapeuticsยทNASDAQ
--
--(--)
OMGA Profile
Omega Therapeutics, Inc.
A clinical-stage biotechnology company that pioneering the first systematic approach to use mRNA therapeutics as a new class of programmable epigenetic medicines
140 First Street, Suite 501, Cambridge, Massachusetts 02141
--
Omega Therapeutics, Inc., was incorporated as a Delaware corporation in July 2016. The company is a clinical-stage biotechnology company that has pioneered a new class of programmable epigenomic mRNA drugs. The company's OMEGA platform utilizes the power of epigenetics and a deep understanding of genomic structure to precisely target and controllably regulate gene expression at the pre-transcriptional level to treat or cure diseases.
